EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Obesity and Metabolic Syndrome: Current Insights and Future Directions

Zaiem Zarkasi, Rajshekhar N Mudaliar, Waseem A Majeed, Akheel A Syed

British Journal of Hospital Medicine · 25.09.2025 · 86 (9) · 1-20

DOI: 10.12968/hmed.2025.0127 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, erschienen am 25.09.2025. Verfasst von Zaiem Zarkasi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity, Bariatric Surgery, Anti-Obesity Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity and metabolic syndrome are global health challenges, significantly increasing risks for type 2 diabetes, cardiovascular and cerebrovascular diseases, and overall mortality. This narrative review aims to discuss the relationship between obesity and metabolic syndrome; the past, present and future of anti-obesity medications including new advances in incretin-based therapies which have enabled patients to achieve significant weight loss and improvement in metabolic parameters; and the role of metabolic/bariatric surgery which remains the most effective durable treatment for severe obesity, with high remission rates of metabolic comorbidities like type 2 diabetes. Multimodal approaches involving the combination of lifestyle, medical and surgical advances will revolutionise our approach to treating obesity and metabolic syndrome in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeObesityBariatric SurgeryAnti-Obesity AgentsWeight LossComorbidityDiabetes Mellitus, Type 2Risk FactorsPrevalenceHumansHealthy LifestyleGlucagon-Like Peptide-1 Receptor AgonistsIncretinsGastric Inhibitory PolypeptideReceptors, Gastrointestinal HormoneTreatment Outcome

Stichwörter der Autor:innen

glucagon-like peptide-1 receptor agonistincretinsmetabolic syndromemetabolic/bariatric surgeryobesityweight loss

Substanzen

Anti-Obesity AgentsGlucagon-Like Peptide-1 Receptor AgonistsIncretinsGastric Inhibitory PolypeptideReceptors, Gastrointestinal Hormone

Autor:innen und Institutionen

  • Endocrinology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
  • Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Zitieren

APA

Zarkasi, Z., Mudaliar, R. N., Majeed, W. A., & Syed, A. A. (2025). Obesity and Metabolic Syndrome: Current Insights and Future Directions. British Journal of Hospital Medicine, 86(9), 1-20. https://doi.org/10.12968/hmed.2025.0127

Vancouver

Zarkasi Z, Mudaliar RN, Majeed WA, Syed AA. Obesity and Metabolic Syndrome: Current Insights and Future Directions. British Journal of Hospital Medicine. 2025;86(9):1-20. doi:10.12968/hmed.2025.0127

BibTeX
@article{Zarkasi2025,
  author = {Zarkasi, Zaiem and Mudaliar, Rajshekhar N and Majeed, Waseem A and Syed, Akheel A},
  title = {Obesity and Metabolic Syndrome: Current Insights and Future Directions},
  journal = {British Journal of Hospital Medicine},
  year = {2025},
  volume = {86},
  number = {9},
  pages = {1--20},
  doi = {10.12968/hmed.2025.0127}
}
Kostenlos starten →